A division of Eli Lilly and Company, Elanco Animal Health markets products worldwide to improve the health of animals. Products are marketed primarily for cattle, poultry, and swine producers. With key operations in North America, Europe, the Middle East and Africa, the Asia-Pacific area, and Latin America, Elanco employs approximately 2,000 people and markets its products in more than 100 countries.
Elanco´s current product line concentrates on four therapeutic classes: antibacterials, parasiticides, anticoccidials, and productivity enhancers. The division conducts its own research on products and target species and benefits from the massive research programs of Lilly Research Laboratories.
|
About
